Search

everythinglearnresearchcommunity

for

Search:↓

The bulb and shoot of Allium longisepalum contain various compounds with potential health benefits, including antioxidant and anti-inflammatory properties.

Baricitinib is effective and safe for treating severe alopecia areata.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Darkened knuckles can be an early sign of insulin resistance.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Bilobetin may help reduce acne by decreasing sebum production.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

A reliable method was developed to measure aristolochic acid-I in rat blood.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Pine resin and abietic acid were found to promote hair growth in mice.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Some dibenzo compounds might help treat cancer with fewer side effects.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Baricitinib may effectively treat oral lichen planus.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

ATP-dependent chromatin-remodeling complexes are crucial for gene regulation, cell differentiation, and organ development in mammals.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

CaBP1 and 2 are important for maintaining the activity of calcium channels necessary for hearing in inner ear cells.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.